Bromo- and Extra-Terminal Domain Inhibitors Induce Mitochondrial Stress in Pancreatic Ductal Adenocarcinoma

Using a combination of patient and syngeneic murine models, scientists investigated the effects of the Bromo- and Extra-Terminal domain drug BMS-986158 on cellular proliferation, organoid growth, cell cycle progression, and mitochondrial metabolic disruption.